IMARC Group, a leading market research company, has recently releases report titled, "Bioprocess Validation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" The global bioprocess validation market size reached US$ 334.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 573.6 Million by 2028, exhibiting a growth rate (CAGR) of 8.78% during 2023-2028.
What is Bioprocess Validation Market?
Bioprocess validation represents the evaluation activities that are conducted during the production and testing of bio-products to maintain the required level of compliance at all phases. They involve extractable, compatibility, integrity, physiochemical, and microbiological testing services as standard methods. These bioprocess validation techniques are extremely cost-effective and aid in evaluating possible contaminants and multiple active pharmaceutical ingredients (APIs) during the development of animal drugs and biological products. They establish scientific evidence that a particular process is competent in delivering quality products. As a result, bioprocess validation methods are extensively utilized by biotechnology and pharmaceutical companies and contract development and manufacturing organizations across the globe.
Request a free sample brochure: https://www.imarcgroup.com/bioprocess-validation-market/requestsample
Bioprocess Validation Market Trends and Drivers:
The escalating need for outsourcing the services in hospitals and clinics to secure compliance with good manufacturing practices (GMP) is among the key factors driving the bioprocess validation market. In addition to this, the implementation of stringent product safety and quality regulations by government bodies is acting as another significant growth-inducing factor. Besides this, the rising prevalence of numerous chronic ailments and the inflating demand for biopharmaceuticals are further catalyzing the market growth.
Moreover, the elevating usage of the services by pharmaceutical companies to monitor the purity, accuracy, safety, and efficacy of drugs while producing novel vaccines and biosimilars and the increasing technological advancements in bio-manufacturing infrastructure are also positively influencing the global market. In line with this, the expanding requirement for bioprocess validation of bioreactors to ensure the scalable and cost-effective manufacturing of medications, the emerging trend of outsourcing laboratory testing services, and the shifting preferences toward personalized medicines are expected to propel the bioprocess validation market over the forecasted period.
Bioprocess Validation Market Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Test Type:
- Extractables Testing Services
- Microbiological Testing Services
- Physiochemical Testing Services
- Integrity Testing Services
- Compatibility Testing Services
- Others
Breakup by Process Component:
- Filter Elements
- Media Containers and Bags
- Freezing And Thawing Process Bags
- Mixing Systems
- Bioreactors
- Transfer Systems
- Others
Breakup by End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development and Manufacturing Organizations
- Others
By Geography:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
- Almac Group
- Biozeen
- Doc S.R.L.
- Eurofins Scientific
- Hangzhou Anow Microfiltration Co. Ltd.
- Hangzhou Cobetter Filtration Equipment Co. Ltd.
- Hangzhou Tianshan Precision Filter Material Co. Ltd.
- Meissner Filtration Products, Inc.
- Merck KGaA, Sartorius AG
- SGS SA and Thermo Fisher Scientific Inc.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
